Our results show that circulatory cortisol levels indeed increased in patients with clinical malaria but that sensitivity of patient PBMCs to ex vivo hydrocortisone is reduced, since the induction of GILZ and FKBP5 mRNA and cAMP responses were impaired. The gene discussed is TSC22D3; the disease is malaria.